Tal Gefen
Impact in
-
- Immunotherapy and Immune Responses
Papers in
-
- Gut microbiota and health 7
- Protein purification and stability 3
- Advanced biosensing and bioanalysis techniques 3
-
- Clostridium difficile and Clostridium perfringens research 3
- Co-authors
- Naama Geva‐Zatorsky (14 shared papers)Eli Gilboa (3 shared papers)Jacob Pitcovski (5 shared papers)É. M. Aizenshtein (5 shared papers)Jacob Vaya (4 shared papers)E.D. Heller (3 shared papers)Soliman Khatib (4 shared papers)Iris Castro (1 shared paper)
- Journals
- Nature Communications (2 papers)Vaccine (2 papers)Experimental Biology and Medicine (1 paper)Frontiers in Cellular and Infection Microbiology (1 paper)Scientific Reports (1 paper)
- Partner nations
- IsraelCanadaUnited States
In The Last Decade
Tal Gefen
21 papers receiving 415 citations
Peers
Comparison fields: 5 of 80
- Immunology 97
- Microbiology 29
- Infectious Diseases 64
- Molecular Biology 217
- Rehabilitation 15
Countries citing papers authored by Tal Gefen
This map shows the geographic impact of Tal Gefen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tal Gefen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tal Gefen more than expected).
Fields of papers citing papers by Tal Gefen
This network shows the impact of papers produced by Tal Gefen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tal Gefen. The network helps show where Tal Gefen may publish in the future.
Co-authors
The 25 scholars most cited alongside Tal Gefen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 59 | |
| 2 | 2017 | 53 | |
| 3 | 2019 | 52 | |
| 4 | 2013 | 47 | |
| 5 | 2014 | 46 | |
| 6 | 2024 | 39 | |
| 7 | 2020 | 32 | |
| 8 | 2022 | 26 | |
| 9 | 2020 | 13 | |
| 10 | 2017 | 12 | |
| 11 | 2022 | 9 | |
| 12 | 2017 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2022 | 4 | |
| 16 | 2009 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2010 | 3 | |
| 20 | 2020 | 2 |
About Tal Gefen
Tal Gefen is a scholar working on Molecular Biology, Infectious Diseases, Immunology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 22 papers that have together received 422 indexed citations. Recurring topics across this work include Gut microbiota and health (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Biosensors and Analytical Detection (3 papers), Protein purification and stability (3 papers), Immunotherapy and Immune Responses (3 papers), Probiotics and Fermented Foods (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). The work is most often cited by research in Immunology (97 citations), Microbiology (29 citations), Infectious Diseases (64 citations), Molecular Biology (217 citations) and Rehabilitation (15 citations). Tal Gefen has collaborated with scholars based in Israel, Canada and United States. Frequent co-authors include Naama Geva‐Zatorsky, Eli Gilboa, Jacob Pitcovski, É. M. Aizenshtein, Jacob Vaya, E.D. Heller, Soliman Khatib, Iris Castro, Darija Muharemagic and Haitham Hajjo. Their work appears in journals such as Nature Communications, Vaccine, Experimental Biology and Medicine, Frontiers in Cellular and Infection Microbiology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.